Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6]
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
- WB
Supplier Data
Western blot - Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6] (AB322041)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The observed Mw of ~45KDa is higher than the predicted Mw due to glycosylation (PMID : 33070381).
All lanes:
Western blot - Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6] (ab322041) at 1/1000 dilution
All lanes:
Human liver tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 45 kDa
false
Exposure time: 114s
- WB
Supplier Data
Western blot - Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6] (AB322041)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : spleen, skeletal muscle(PMID : 20442402)
The observed Mw of ~45KDa is higher than the predicted Mw due to glycosylation (PMID : 33070381).
The identity of the lower MW band at approximately 18 kDa (in lane 1) is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6] (ab322041) at 1/1000 dilution
Lane 1:
Human plasma at 20 µg
Lane 2:
Human spleen tissue lysate at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Lane 4:
Human testis tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 45 kDa,36 kDa
false
Exposure time: 180s
- Dot
Supplier Data
Dot Blot - Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6] (AB322041)
Dot blot analysis of Orosomucoid 1 + Orosomucoid 2 using ab322041 at 1 : 1000 (0.508 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 10,000 dilution.
Lane1 : His-tagged human ORM1 protein
Lane2 : His-tagged human ORM2 protein
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Dot Blot - Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6] (ab322041) at 1/1000 dilution
Lane 1:
His-tagged human ORM1 protein at 5 ng
Lane 2:
His-tagged human ORM2 protein at 5 ng
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-Orosomucoid 1 + Orosomucoid 2 antibody [EPR26603-6] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AGP has significant roles in modulating immune responses and transport functions. This molecule interacts with various drugs and hormones due to its binding capacity thereby influencing their bioavailability and distribution. It forms part of a complex dynamic system that helps modulate the body's response to acute inflammatory stimuli. As a glycoprotein AGP plays a role in processes such as cell-to-cell communication and cell signaling which are essential for maintaining homeostasis during stress responses.
Pathways
AGP is integrally involved in the acute-phase response pathway that gets activated during infection or injury. This pathway leads to the dramatic increase of AGP and other acute-phase proteins like C-reactive protein (CRP) in the blood. Furthermore AGP is related to the immune response pathways where it can modulate the activity of various immune cells. Its binding interactions with cytokines and other inflammatory modulators emphasize its role in regulating inflammation and immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Alternative Names
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com